Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients

  1. Roldán, V.
  2. Marín, F.
  3. Muiña, B.
  4. Torregrosa, J.M.
  5. Hernández-Romero, D.
  6. Valdés, M.
  7. Vicente, V.
  8. Lip, G.Y.H.
Revista:
Journal of the American College of Cardiology

ISSN: 0735-1097,  1558-3597

Any de publicació: 2011

Volum: 57

Número: 25

Pàgines: 2496-2504

Tipus: Article

DOI: 10.1016/J.JACC.2010.12.033 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus